Positron Corporation (OTC:POSC) cut off the climb again. Yesterday, the stock lost 37.88% of its price, while its traded volume 
jumped over 11 million shares.
In fact, that’s the usual chart movement of POSC lately, which makes its market position quite unstable. Though, Positron is determined to get the climb again.
Yesterday, the company reported that King Fahad Specialist Hospital was the first to offer Positron Emission Mammography in the Middle East. The news came up just when POSC took the way down and now it is interesting if the stock will get back on track.
Positron Corp. is a molecular imaging company focusing on nuclear cardiology and utilizing its proprietary product line to provide unique solutions to the Nuclear Medicine community. Last week, the company’s stock was moving down despite promotions and currently its next move is hard to be predicted.[BANNER]
According to the company’s latest financial report, Positron’s sales got higher, however, its operating loss jumped up and the net loss doubled as compared to the year before. Besides, the report was full of risk factors which are beyond the company’s control.
Though, POSC doesn’t seem much worried about its financial condition and keeps relying on news to pump it its stock price.
